Caris Life Sciences to Report Second Quarter 2025 Financial Results on August 12, 2025
Caris Life Sciences (NASDAQ: CAI), an AI TechBio company and precision medicine pioneer, has scheduled its second quarter 2025 financial results announcement for August 12, 2025. The company will host a conference call and webcast at 3:30 p.m. CT (4:30 p.m. ET) to discuss the results. A replay will be available on the company's Investor Relations website after the call.
Caris Life Sciences (NASDAQ: CAI), un'azienda TechBio specializzata in intelligenza artificiale e pioniera della medicina di precisione, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 12 agosto 2025. La società terrà una conference call e una webcast alle 15:30 CT (16:30 ET) per discutere i risultati. Una registrazione sarà disponibile sul sito web delle Relazioni con gli Investitori dopo la chiamata.
Caris Life Sciences (NASDAQ: CAI), una empresa TechBio de IA y pionera en medicina de precisión, ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el 12 de agosto de 2025. La compañía realizará una llamada conferencia y una transmisión en vivo a las 3:30 p.m. CT (4:30 p.m. ET) para discutir los resultados. Una repetición estará disponible en el sitio web de Relaciones con Inversionistas después de la llamada.
Caris Life Sciences (NASDAQ: CAI)는 AI 테크바이오 기업이자 정밀 의학 선구자로서, 2025년 2분기 재무 실적 발표를 2025년 8월 12일에 예정하고 있습니다. 회사는 실적 발표를 논의하기 위해 오후 3:30 CT (오후 4:30 ET)에 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다. 통화 후 회사 투자자 관계 웹사이트에서 다시보기 서비스를 제공할 예정입니다.
Caris Life Sciences (NASDAQ : CAI), une entreprise TechBio spécialisée en IA et pionnière de la médecine de précision, a programmé l'annonce de ses résultats financiers du deuxième trimestre 2025 pour le 12 août 2025. La société organisera une conférence téléphonique et une diffusion en direct à 15h30 CT (16h30 ET) pour discuter des résultats. Une rediffusion sera disponible sur le site des Relations Investisseurs après l'appel.
Caris Life Sciences (NASDAQ: CAI), ein AI TechBio-Unternehmen und Pionier der Präzisionsmedizin, hat die Bekanntgabe der Finanzergebnisse für das zweite Quartal 2025 für den 12. August 2025 geplant. Das Unternehmen wird um 15:30 Uhr CT (16:30 Uhr ET) eine Telefonkonferenz und ein Webcast veranstalten, um die Ergebnisse zu besprechen. Eine Aufzeichnung wird nach der Telefonkonferenz auf der Investor-Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
Caris Life Sciences will host a conference call and live webcast at 3:30 p.m. CT (4:30 p.m. ET) to discuss the financial results.
Conference Call Details:
Date: Tuesday, August 12, 2025
Time: 3:30 p.m. CT (4:30 p.m. ET)
Live Webcast: https://edge.media-server.com/mmc/p/hfsyg967
A replay of the webcast will be available shortly after the conclusion of the call on the Investor Relations section of the Caris Life Sciences website at CarisLifeSciences.com.
About Caris Life Sciences
Caris Life Sciences® (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer that is actively developing and commercializing innovative solutions to transform healthcare. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced AI and machine learning algorithms at scale, Caris has created the large-scale, multimodal clinico-genomic database and computing capability needed to analyze and further unravel the molecular complexity of disease. This convergence of next-generation sequencing, AI and machine learning technologies, and high-performance computing provides a differentiated platform to develop the latest generation of advanced precision medicine diagnostic solutions for early detection, diagnosis, monitoring, therapy selection and drug development.
Caris was founded with the belief and vision that combining a vast set of consistently generated molecular information with robust data-driven insights could realize the potential of precision medicine for patients. Headquartered in
Caris Life Sciences Media:
Corporate Communications
CorpComm@CarisLS.com
214.294.5606
Investor Relations:
Narendra Chokshi
Senior Vice President, Corporate Development
nchokshi@carisls.com
917.689.3511
View original content to download multimedia:https://www.prnewswire.com/news-releases/caris-life-sciences-to-report-second-quarter-2025-financial-results-on-august-12-2025-302511341.html
SOURCE Caris Life Sciences
FAQ
When will Caris Life Sciences (CAI) report Q2 2025 earnings?
What time is the Caris Life Sciences (CAI) Q2 2025 earnings call?
How can I access Caris Life Sciences (CAI) Q2 2025 earnings call?
Where can I find the replay of Caris Life Sciences (CAI) Q2 2025 earnings call?
